Related Experiment Video
Updated: Jan 20, 2026
Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles
Published on: November 1, 2017
Integrin targeted delivery of chemotherapeutics
11. National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda, MD;
Targeted chemotherapy uses RGD peptides to deliver drugs specifically to integrins, like αvβ3, enhancing treatment efficacy. This approach localizes drug action, maximizing the therapeutic index and minimizing side effects.
Area of Science:
- Biomedical Engineering
- Pharmacology
- Oncology
Background:
- Integrins are cell surface receptors crucial for cell interactions and tumor development.
- Targeted drug delivery aims to increase therapeutic efficacy by localizing chemotherapy to specific sites.
- Integrin αvβ3 is a key target due to its role in angiogenesis and tumor progression.
Purpose of the Study:
- To review advances in targeted chemotherapy delivery utilizing integrin αvβ3.
- To discuss the design and applications of RGD peptide-chemotherapeutic conjugates.
- To highlight strategies for maximizing the therapeutic index of chemotherapeutic agents.
Main Methods:
- Conjugation of arginine-glycine-aspartic acid (RGD) peptide ligands with chemotherapeutic agents.
- Development of RGD peptide-drug conjugates, including small molecules, proteins, and nanoparticles.
- Review of studies focusing on integrin αvβ3 as a target for drug delivery.
Main Results:
- RGD peptides show high affinity and selectivity for integrins, especially αvβ3.
- Various chemotherapeutic agents can be effectively conjugated with RGD peptides.
- Integrin-targeted therapies demonstrate potential for localized drug delivery and enhanced treatment outcomes.
Conclusions:
- RGD peptide-integrin targeting offers a promising strategy for enhancing chemotherapy's therapeutic index.
- The design of RGD peptide-drug conjugates is critical for successful targeted delivery.
- Further research into these conjugates holds significant potential for cancer treatment.
Related Concept Videos
06:40Automated Delivery of Microfabricated Targets for Intense Laser Irradiation Experiments
08:09Methionine Functionalized Biocompatible Block Copolymers for Targeted Plasmid DNA Delivery
10:26Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles
14:10Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
01:10Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
01:15Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...